Literature DB >> 1847479

Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus.

S Carpenter1, S Alexandersen, M J Long, S Perryman, B Chesebro.   

Abstract

An avirulent, field-derived isolate of equine infectious anemia virus (EIAV), designated MA-1, was molecularly cloned, and the complete nucleotide sequence was determined for the 3' half of the viral genome. Comparisons between MA-1 and the prototype Wyoming strain of EIAV identified a 66-nucleotide stretch between CAAT (-91) and TATAA (-25) in the U3 region of the long terminal repeat, where sequence divergence was as high as 39.3%. The polymerase chain reaction was used to amplify and clone long terminal repeat sequences from Th-1, the in vivo parental stock of MA-1. Results indicated that the nucleotide sequences of MA-1 and Th-1 clones were less variable than was observed between MA-1 and Wyoming. However, MA-1 and Th-1 markedly differed in the types of enhancer sequences located in the hypervariable region. These results suggest that variation in lentivirus regulatory sequences may be important in EIAV host cell tropism and pathogenesis.

Entities:  

Mesh:

Year:  1991        PMID: 1847479      PMCID: PMC239946     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations.

Authors:  A Meyerhans; R Cheynier; J Albert; M Seth; S Kwok; J Sninsky; L Morfeldt-Månson; B Asjö; S Wain-Hobson
Journal:  Cell       Date:  1989-09-08       Impact factor: 41.582

2.  Production of equine infectious anemia antigen in a persistently infected cell line.

Authors:  W A Malmquist; D Barnett; C S Becvar
Journal:  Arch Gesamte Virusforsch       Date:  1973

Review 3.  Proto-oncogene fos: complex but versatile regulation.

Authors:  I M Verma; P Sassone-Corsi
Journal:  Cell       Date:  1987-11-20       Impact factor: 41.582

4.  Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat.

Authors:  J Sodroski; C Rosen; F Wong-Staal; S Z Salahuddin; M Popovic; S Arya; R C Gallo; W A Haseltine
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

5.  Detailed transcription map of Aleutian mink disease parvovirus.

Authors:  S Alexandersen; M E Bloom; S Perryman
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

6.  Differences in cytopathogenicity and host cell range among infectious molecular clones of human immunodeficiency virus type 1 simultaneously isolated from an individual.

Authors:  K Sakai; S Dewhurst; X Y Ma; D J Volsky
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

7.  Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.

Authors:  E J Duh; W J Maury; T M Folks; A S Fauci; A B Rabson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

8.  Nucleotide sequence and genomic organization of Aleutian mink disease parvovirus (ADV): sequence comparisons between a nonpathogenic and a pathogenic strain of ADV.

Authors:  M E Bloom; S Alexandersen; S Perryman; D Lechner; J B Wolfinbarger
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

9.  Biologic features of HIV-1 that correlate with virulence in the host.

Authors:  C Cheng-Mayer; D Seto; M Tateno; J A Levy
Journal:  Science       Date:  1988-04-01       Impact factor: 47.728

10.  Biological characterization of paired human immunodeficiency virus type 1 isolates from blood and cerebrospinal fluid.

Authors:  F Chiodi; A Valentin; B Keys; S Schwartz; B Asjö; S Gartner; M Popovic; J Albert; V A Sundqvist; E M Fenyö
Journal:  Virology       Date:  1989-11       Impact factor: 3.616

View more
  24 in total

1.  Nucleotide sequence analysis of Aleutian mink disease parvovirus shows that multiple virus types are present in infected mink.

Authors:  E Gottschalck; S Alexandersen; A Cohn; L A Poulsen; M E Bloom; B Aasted
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Characterization of variable regions in the envelope and S3 open reading frame of equine infectious anemia virus.

Authors:  S Alexandersen; S Carpenter
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Genetic variation in the long terminal repeat associated with the transition of Chinese equine infectious anemia virus from virulence to avirulence.

Authors:  Lili Wei; Xiujuan Fan; Xiaoling Lu; Liping Zhao; Wenhua Xiang; Xiaoyan Zhang; Fei Xue; Yiming Shao; Rongxian Shen; Xiaojun Wang
Journal:  Virus Genes       Date:  2009-01-07       Impact factor: 2.332

4.  Biological characterization of Rev variation in equine infectious anemia virus.

Authors:  M Belshan; M E Harris; A E Shoemaker; T J Hope; S Carpenter
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Binding of equine infectious anemia virus rev to an exon splicing enhancer mediates alternative splicing and nuclear export of viral mRNAs.

Authors:  M Belshan; G S Park; P Bilodeau; C M Stoltzfus; S Carpenter
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

6.  Localized sequence heterogeneity in the long terminal repeats of in vivo isolates of equine infectious anemia virus.

Authors:  W Maury; S Perryman; J L Oaks; B K Seid; T Crawford; T McGuire; S Carpenter
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

7.  Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony.

Authors:  C Leroux; C J Issel; R C Montelaro
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

8.  Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus.

Authors:  D L Lichtenstein; C J Issel; R C Montelaro
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

9.  Identification of the activation domain of equine infectious anemia virus rev.

Authors:  R A Fridell; K M Partin; S Carpenter; B R Cullen
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

10.  Monocyte maturation controls expression of equine infectious anemia virus.

Authors:  W Maury
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.